Mefcom Capital Markets shareholders approve subsidiary sale, related party deal
Mefcom Capital Markets Limited completed its AGM on August 8, 2026, approving the sale of its subsidiary Mefcom Securities Limited and a related party transaction with MD Vijay Mehta. Shareholders also ratified FY26 financials and approved excess managerial remuneration for FY26 and FY27.

*this image is generated using AI for illustrative purposes only.
Mefcom Capital Markets shareholders approved the sale of its entire shareholding in subsidiary Mefcom Securities Limited and sanctioned a related party transaction with Managing Director Vijay Mehta during its Annual General Meeting on August 8, 2026. The meeting, which concluded at 1:30 PM in New Delhi, also saw the ratification of audited financial statements for the fiscal year ended March 31, 2026 (FY26), and approval for managerial remuneration exceeding limits prescribed under Section 197 of the Companies Act, 2013 for both FY26 and FY27.
The proceedings were conducted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Quorum was established in accordance with the Companies Act, 2013. Voting was conducted via remote e-voting from August 5 to August 7, 2026, with a cut-off date of August 1, 2026, followed by ballot paper voting for attendees. Brij Kishore Sharma (FCS-6206), a practicing Company Secretary, was appointed as the scrutinizer to ensure fair and transparent voting procedures.
The Board, chaired by Managing Director Vijay Mehta, presented seven resolutions for shareholder approval. Alongside the ordinary business of adopting financial statements and appointing a director in place of Sameer Rajendra Purohit (DIN: 05002079), who retired by rotation, shareholders addressed several special business items. These included approving the continuation of Dr. Shri Ram Khanna (DIN: 07723472) as a Non-Executive Independent Director upon attaining the age of 75 years.
| Resolution No. | Type | Matter of Resolution |
|---|---|---|
| 1 | Ordinary | Adoption of Audited Financial Statements (Standalone & Consolidated) and reports for year ended March 31, 2026 |
| 2 | Ordinary | Appointment of Director in place of Mr. Sameer Rajendra Purohit (DIN: 05002079) retiring by rotation |
| 3 | Ordinary | Approval of related party transaction between Mr. Vijay Mehta, Promoter and MD, and the Company |
| 4 | Ordinary | Approval of sale of entire shareholding in subsidiary Mefcom Securities Limited |
| 5 | Ordinary | Continuation of Dr. Shri Ram Khanna (DIN: 07723472) as Non-Executive Independent Director |
| 6 | Special | Approval of managerial remuneration paid to Executive Directors in excess of Section 197 limits for FY26 |
| 7 | Special | Approval of managerial remuneration payable to Executive Directors in excess of Section 197 limits for FY27 |
Key Governance and Strategic Decisions
The approval of the sale of the entire shareholding in Mefcom Securities Limited marks a significant structural change for the group, potentially streamlining operations or reallocating capital. Simultaneously, the ratification of the related party transaction with Promoter and Managing Director Vijay Mehta underscores ongoing governance oversight required for such dealings under SEBI regulations.
The Board’s request for approval of managerial remuneration exceeding statutory limits for two consecutive financial years (FY26 and FY27) indicates a strategic focus on retaining key executive talent despite regulatory caps. No queries were raised by members during the session, suggesting broad alignment with the Board’s proposals. The voting results and scrutinizer’s report were disseminated via stock exchanges within 48 hours of the meeting’s conclusion.
Historical Stock Returns for Mefcom Capital Markets
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.50% | +1.65% | -0.80% | -20.36% | -38.53% | +153.47% |
How will the proceeds from the sale of Mefcom Securities Limited be allocated, and will this divestment signal a strategic shift away from the securities business?
What specific terms define the related party transaction with Managing Director Vijay Mehta, and how might this impact minority shareholder confidence in future governance oversight?
Given the approval of managerial remuneration exceeding Section 197 limits for two consecutive years, what performance metrics or retention strategies justify these higher payouts to executive directors?


































